4//SEC Filing
MOMENTA PHARMACEUTICALS INC 4
Accession 0001179110-16-019715
CIK 0001235010operating
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 12:41 PM ET
Size
8.0 KB
Accession
0001179110-16-019715
Insider Transaction Report
Form 4
Bishop John E
Senior VP, Pharmaceutical Scie
Transactions
- Sale
Common Stock
2016-02-22$9.71/sh−868$8,428→ 107,415 total - Sale
Common Stock
2016-02-19$9.64/sh−1,576$15,193→ 108,283 total - Sale
Common Stock
2016-02-19$9.65/sh−404$3,899→ 109,859 total
Footnotes (3)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2009.
- [F2]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2015.
- [F3]This transaction was executed in multiple trades at prices ranging from $9.62 to $9.83. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
MOMENTA PHARMACEUTICALS INC
CIK 0001235010
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001235010
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 12:41 PM ET
- Size
- 8.0 KB